Sign Up
OverviewAPI
Canopy Growth, a Canadian cannabis company, has seen a drastic drop of over 98% in its stock value since 2019. Despite revenue decline, it strives for profitability, with a focus on its cannabis business and a plan to achieve positive EBITDA across all business units by 2024. The company's Canadian medical business shows consistent growth, while it aims to reintroduce its Wana brand in the Canadian adult-use cannabis market.

Ask a question